{"university":{"openalex_id":"I193531525","name":"George Washington University"},"topic":"bladder-aging","total_matching":1,"offset":0,"next_offset":null,"records":[{"doi":"https://doi.org/10.1016/s0197-2456(99)00024-0","title":"Design and Baseline Characteristics for the Aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II)","source_url":"https://doi.org/10.1016/s0197-2456(99)00024-0","source_name":"Controlled Clinical Trials","cited_by_count":258,"is_open_access":false,"openalex_work_id":"W1990675333","publication_date":"1999-10-01","publication_year":1999,"university_research_work_topics":[{"topic_slug":"bladder-aging"}]}],"automation_disclosure":"Generated automatically from cited source metadata. No scientist, clinician, researcher, editor, or human reviewer evaluates this publication before release."}